These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15611446)

  • 1. Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study.
    Stockfleth E; Christophers E; Benninghoff B; Sterry W
    Arch Dermatol; 2004 Dec; 140(12):1542. PubMed ID: 15611446
    [No Abstract]   [Full Text] [Related]  

  • 2. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
    Gupta AK; Davey V; Mcphail H
    J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.
    Jorizzo J; Dinehart S; Matheson R; Moore JK; Ling M; Fox TL; McRae S; Fielder S; Lee JH
    J Am Acad Dermatol; 2007 Aug; 57(2):265-8. PubMed ID: 17512087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is imiquimod effective and safe for actinic keratosis?
    Walker JK; Koenig C
    J Fam Pract; 2003 Mar; 52(3):184-5. PubMed ID: 12620165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod 5% cream for the treatment of actinic keratoses.
    Somani N; Rivers JK
    Skin Therapy Lett; 2005 Mar; 10(2):1-6. PubMed ID: 15986078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials.
    Lebwohl M; Dinehart S; Whiting D; Lee PK; Tawfik N; Jorizzo J; Lee JH; Fox TL
    J Am Acad Dermatol; 2004 May; 50(5):714-21. PubMed ID: 15097955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod cream in the treatment of actinic keratoses.
    Persaud A; Lebwohl M
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disseminated actinic keratoses. Comparison of topical photodynamic therapy with 5-aminolevulinic acid and topical 5% imiquimod cream].
    Cerburkovas O; Krause M; Ulrich J; Bonnekoh B; Gollnick H
    Hautarzt; 2001 Oct; 52(10 Pt 2):942-6. PubMed ID: 11715389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod (Aldara) for actinic keratoses.
    Med Lett Drugs Ther; 2004 May; 46(1183):42-4. PubMed ID: 15159659
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of actinic keratosis with topical imiquimod (Aldara): the cutaneous erosion appears beneficial].
    Campanelli A; Salomon D; Saurat JH
    Ann Dermatol Venereol; 2004 Apr; 131(4):387-8. PubMed ID: 15258517
    [No Abstract]   [Full Text] [Related]  

  • 12. Actinic keratosis treated with an immune response modifier: a case report of six patients.
    Bianchi L; Campione E; Marulli GC; Costanzo A; Chimenti S
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():39-41. PubMed ID: 14616813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating actinic keratoses with imiquimod.
    Dixon A
    Aust Fam Physician; 2007 May; 36(5):341-2. PubMed ID: 17492069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of actinic keratosis studies with imiquimod 5% cream.
    Tran H; Chen K; Shumack S
    Br J Dermatol; 2003 Nov; 149 Suppl 66():37-9. PubMed ID: 14616347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
    Stockfleth E; Meyer T; Benninghoff B; Salasche S; Papadopoulos L; Ulrich C; Christophers E
    Arch Dermatol; 2002 Nov; 138(11):1498-502. PubMed ID: 12437457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.
    Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
    Br J Dermatol; 2007 Dec; 157(6):1132-47. PubMed ID: 17944981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of actinic keratoses.
    Lang PG
    Compr Ther; 2003; 29(2-3):108-14. PubMed ID: 14606340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
    Oster-Schmidt C; Altmeyer P; Markus S
    J Dtsch Dermatol Ges; 2003 Oct; 1(10):790-6. PubMed ID: 16281815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head.
    Alomar A; Bichel J; McRae S
    Br J Dermatol; 2007 Jul; 157(1):133-41. PubMed ID: 17501955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology.
    Szeimies RM; Gerritsen MJ; Gupta G; Ortonne JP; Serresi S; Bichel J; Lee JH; Fox TL; Alomar A
    J Am Acad Dermatol; 2004 Oct; 51(4):547-55. PubMed ID: 15389189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.